| Janssen-Cilag AG - Xeplion 50 mg, Depot-Injektionssuspension in einer Fertigspritze |
| 60466 | | 02 | | Xeplion 50 mg | | Depot-Injektionssuspension in einer Fertigspritze | | N05AX13 | | Paliperidone | | 15.12.2010 | | |
|
| Composition |
| paliperidonum 50 mg ut paliperidoni palmitas, polysorbatum 20, macrogolum 4000, acidum citricum monohydricum, dinatrii phosphas, natrii dihydrogenophosphas monohydricus, natrii hydroxidum, aqua ad iniectabile ad suspensionem pro 0.5 ml corresp. natrium 1.834 mg. |
| Packungsbestandteile |
| Retardsuspension zur intramuskulären Injektion | | | | | | | | Active Agent | Dose |
|---|
| Paliperidonum | 50 mg |
| | BAG: Active Agent | Dose |
|---|
| Paliperidonum | 50 mg |
| | | | Inactive agents | Dose |
|---|
| Citric Acid Monohydrate | | | Disodium Phosphate | | | Macrogol | 4000 | | Sodium Dihydrogenophosphate Monohydrate | | | Sodium Hydroxide | | | Polysorbatum 20 | |
| |
|
| Package number | Package Size | EFP | CP | Category | SL | Out of trade (MedRef) |
|---|
| 002 | syringe(s) | 205.19 | 233.85 | B | SL | Yes |
|
